Print Friendly, PDF & Email

Advanced Technology May Hold Promise in Management of Cancer, Neurodegenerative and Cardiac Diseases

Combining the superb soft tissue contrast of MR (magnetic resonance), the exceptional metabolic insight of PET (positron emission tomography), and the precise anatomical reference of CT (computed tomography), enabled by a patient transport system and image fusion, may hold promise for managing patient care. The combination of these technologies is producing striking images of the brain, breast and prostate, helping doctors see fine vessel detail, visualize cardiac anatomy and function, detect small lesions and monitor response therapy.

Watch Gustav von Schulthess, MD, PhD, Department of Medical Radiology, University Hospital Zurich in Switzerland and his researchers as they study the clinical value of PET/CT+MR using the GE Healthcare PET/CT+ MR tri-modality solution.